A new commentary from National Institutes of Health scientists asserts that engaging men in HIV prevention and care is essential to the goal of ending the HIV pandemic. The article by Adeola Adeyeye, M.D., M.P.A., and David ...
Nov 29, 2018
0
1
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards ...
Nov 29, 2018
0
0
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends HIV screening for individuals aged 15 to 65 years, including all pregnant women, and pre-exposure prophylaxis (PrEP) should be offered to those at ...
Nov 21, 2018
0
0
There is a negligible risk of transmitting HIV during sex when a person living with HIV is on antiretroviral therapy and maintains a viral load under a specific threshold, according to a study in CMAJ (Canadian Medical Association ...
Nov 19, 2018
0
3
Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical ...
Nov 15, 2018
0
37
The latest World Health Organization (WHO) recommendations published in July 2018 advocate first-line treatment of HIV infection using dolutegravir (DTG) as an alternative to treatment with efavirenz at 400 mg (EFV400). Until ...
Nov 1, 2018
0
0
A United Nations initiative backed by global experts has set its sights on an ambitious programme to bring an end to the AIDS epidemic by 2030.
Oct 23, 2018
0
0
Immunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of tumour types—but little is known about its safety for HIV-positive cancer patients. A study ...
Oct 20, 2018
0
0
Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers in the body, threatening to rise to dangerous levels ...
Sep 26, 2018
0
95
A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health. The early-phase clinical trial will evaluate whether periodic infusions of two highly ...
Sep 20, 2018
0
0
